-
公开(公告)号:KR1020120071530A
公开(公告)日:2012-07-03
申请号:KR1020100133111
申请日:2010-12-23
Applicant: 숙명여자대학교산학협력단
IPC: A61K31/35 , A61K31/352 , A61P19/10 , A61P19/00
Abstract: PURPOSE: A composition containing eriodictyol compounds or salt thereof is provided to suppress osteoclast differentiation by RANKL and bone absorption. CONSTITUTION: A composition for preventing or treating bone diseases contains eriodictyol compounds of chemical formula 1 or salt thereof as an active ingredient. The bone diseases include osteoporosis, rachitis, malacosteon, rheumatic osteoporosis, degenerative bone diseases, bone metastatic lesion, or periodontal diseases. A health functional food for preventing or treating bone metabolic diseases contains the compound of chemical formula 1 or salt thereof as an active ingredient.
Abstract translation: 目的:提供含有二碘型酚化合物或其盐的组合物以抑制RANKL和骨吸收的破骨细胞分化。 构成:用于预防或治疗骨疾病的组合物含有化学式1的卤代醇化合物或其盐作为活性成分。 骨疾病包括骨质疏松症,腹泻,马可康斯特氏菌,风湿性骨质疏松症,退行性骨病,骨转移性病变或牙周病。 用于预防或治疗骨代谢疾病的健康功能食品含有化学式1的化合物或其盐作为活性成分。